IRF4 is a surrogate immunohistochemical marker for the “activated B cell” subtype of DLBCLs and is also an essential survival factor for activated B cell lymphomas in humans [63,64]. The gene discussed is IRF4; the disease is B-cell non-Hodgkin lymphoma.